FAMEDS founder condemns FDA decision on Avastin for metastatic breast cancer

[News]

Breast cancer patients, their families and advocates expressed extreme disappointment at today's Food and Drug Administration (FDA) decision to remove the anti-cancer drug Avastin from the approved medication list for treatment of late stage breast cancer.

More... (http://www.news-medical.net/news/20111119/FAMEDS-founder-condemns-FDA-decision-on-Avastin-for-metastatic-breast-cancer.aspx)